DrugCard is an AI-driven platform that automates pharmacovigilance workflows, focusing on local medical literature monitoring. It helps drug safety teams screen journals in over 100 languages across 122+ countries, covering more than 2,200 local journals. The platform uses proprietary OCR technology to recognise poorly scanned texts with up to 99% accuracy, and claims 50–70% time savings compared to manual screening.
Key Features
- Multi-language support (100+ languages) for keyword search in scripts like Greek, Hindi, Arabic, and Japanese.
- Continuous monitoring of local journals with instant email notifications and weekly summary reports.
- Scalable to new markets; average 2–3 weeks to add journals for a new country.
- AI-driven hit detection, reportedly finding 3–5 times more relevant mentions than manual processes.
Who It’s For
Pharmacovigilance specialists, drug safety teams, and pharmaceutical companies needing to manage local literature screening, comply with regulatory requirements, and free up staff for higher-value tasks like signal detection and risk assessment.
Key Benefits
- 50–70% time savings on literature screening
- 3–5 times more relevant drug mentions detected
- 99% OCR accuracy on average scanned texts
- Supports 100+ languages and 2,200+ local journals